| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.28 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |